Zurich Cantonal Bank’s Myovant Sciences Ltd. MYOV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q1
Sell
-3,917
Closed -$106K 2893
2022
Q4
$106K Hold
3,917
﹤0.01% 2235
2022
Q3
$70K Hold
3,917
﹤0.01% 2450
2022
Q2
$49K Hold
3,917
﹤0.01% 2599
2022
Q1
$52K Hold
3,917
﹤0.01% 2514
2021
Q4
$61K Hold
3,917
﹤0.01% 2680
2021
Q3
$88K Hold
3,917
﹤0.01% 2409
2021
Q2
$89K Hold
3,917
﹤0.01% 2269
2021
Q1
$81K Sell
3,917
-1,601
-29% -$36.4K ﹤0.01% 2238
2020
Q4
$152K Hold
5,518
﹤0.01% 2005
2020
Q3
$78K Hold
5,518
﹤0.01% 2099
2020
Q2
$114K Hold
5,518
﹤0.01% 1877
2020
Q1
$42K Hold
5,518
﹤0.01% 2023
2019
Q4
$86K Buy
5,518
+3,154
+133% +$31.8K ﹤0.01% 1816
2019
Q3
$12K Buy
+2,364
New +$17.5K ﹤0.01% 2535

Other funds holding MYOV

Zurich Cantonal Bank's MYOV Position: Q1 2023 in Review

Zurich Cantonal Bank sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 3,917 shares — an estimated $106K sold.

Zurich Cantonal Bank first reported a position in MYOV in Q3 2019 and held it in 14 quarters. The position peaked at $152K in Q4 2020. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

  • Zurich Cantonal Bank reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
  • Zurich Cantonal Bank sold 3,917 Myovant Sciences Ltd. shares in Q1 2023, an estimated $106K.
  • Zurich Cantonal Bank first reported a position in Myovant Sciences Ltd. in Q3 2019 and held it in 14 quarters.
  • Zurich Cantonal Bank's Myovant Sciences Ltd. position peaked at $152K in Q4 2020.
  • 2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Zurich Cantonal Bank's 13F filing for Q1 2023, filed 8 May 2023.